Tag: U.S. Drug Enforcement Administration
Five Questions With: Vito D. Buonomano
Vito D. Buonomano is the owner of Providence-based energy company Northeast Solar & Wind Power LLC. He recently launched the Fentanyl Awareness Foundation to...
Marijuana reclassification not expected until after presidential election
WASHINGTON (AP) – A decision on whether to reclassify marijuana as a less dangerous drug in the U.S. won't come until after the November...
Pot regulation proposal leaves banking problem
The Biden administration’s move to reclassify marijuana as a less-dangerous controlled drug was hailed as a monumental step in reshaping national policy. But it...
Butler garners ‘Gold Seal’ from accreditation group
PROVIDENCE – Butler Hospital has earned The Joint Commission’s Gold Seal of Approval for its partial hospital and intensive outpatient programs in its Providence...
RIDOH, BHDDH partner on new Buprenorphine Hotline
CRANSTON – Launched this month, a new state hotline is helping people with opioid addiction, or who are suffering from opioid withdrawal, find help...
CVS subpoenaed by U.S. over pharmacies’ role in opioid crisis
NEW YORK – CVS Health Corp. said it received a subpoena on behalf of the U.S. Drug Enforcement Administration, asking the company for information...
A reckoning for opioid supply chain
According to U.S. Drug Enforcement Administration numbers examined by the Washington Post, nearly 100,000 people died in the United States from opioid addiction or...
Justice Department, DEA propose reduction of opioid manufacturing quotas
WASHINGTON D.C. — The U.S. Department of Justice and U.S. Drug Enforcement Administration have proposed reducing controlled substance manufacturing by between 7 and 15 percent in...